Kato Hiroyuki, Hamada Takashi, Kuriyama Naohisa, Ito Takahiro, Magawa Shoichi, Azumi Yoshinori, Kishiwada Masashi, Mizuno Shugo, Usui Masanobu, Sakurai Hiroyuki, Isaji Shuji
Department of Hepatobiliary Pancreatic and Transplant Surgery, Mie University Graduate School of Medicine, Tsu, Mie, Japan.
Hepatol Res. 2017 Mar;47(3):E132-E141. doi: 10.1111/hepr.12740. Epub 2016 Jun 18.
The precise mechanism by which prophylactic splenectomy reduces hepatic ischemia-reperfusion injury (IRI) are still unclear. In this study, we focused on the histological changes of spleen during hepatic IRI, and tested how splenectomy provided cytoprotective effects against hepatic IRI.
Rats underwent 70% warm hepatic IRI with or without splenectomy prior to IRI. To determine whether splenic congestion by itself induces liver damage in the absence of hepatic IRI, we also undertook a splenic vein clamp model.
Liver injury and macrophage and neutrophil infiltration into the liver after reperfusion were significantly depressed in the animals with prophylactic splenectomy, compared to those without splenectomy. Histology of the spleens showed noted congestion during hepatic ischemia (hepatic hilar clamp), which promptly disappeared after declamping. At 6 and 24 h after reperfusion, the spleens showed remarkable recongestion and parenchymal damage, and the splenic venous level of interleukin-2, which is secreted by T cells and enhances macrophage recruitment, and its mRNA levels within the spleen were significantly elevated. In the splenic vein clamp model, the splenic vein clamp by itself produced a certain liver injury and macrophage infiltration within liver even without hepatic IRI.
Spleen plays an important role as an accelerator in hepatic IRI, because splenic congestion and parenchymal damage during ischemia-reperfusion promote splenic IL-2 excretion and macrophage infiltration within the liver, which in turn exacerbate hepatic injury.
预防性脾切除术减轻肝脏缺血再灌注损伤(IRI)的确切机制仍不清楚。在本研究中,我们聚焦于肝脏IRI期间脾脏的组织学变化,并测试脾切除术如何对肝脏IRI提供细胞保护作用。
大鼠在IRI前接受70%的温热肝脏IRI,部分大鼠同时行脾切除术。为确定在无肝脏IRI的情况下脾淤血本身是否会导致肝损伤,我们还建立了脾静脉夹闭模型。
与未行脾切除术的动物相比,预防性脾切除术后再灌注时肝脏损伤以及巨噬细胞和中性粒细胞向肝脏的浸润明显减轻。脾脏组织学显示,在肝脏缺血(肝门部夹闭)期间脾脏出现明显淤血,夹闭解除后淤血迅速消失。再灌注后6小时和24小时,脾脏出现明显的再淤血和实质损伤,由T细胞分泌并促进巨噬细胞募集的白细胞介素-2的脾静脉水平及其在脾脏内的mRNA水平显著升高。在脾静脉夹闭模型中,即使没有肝脏IRI,脾静脉夹闭本身也会导致一定程度的肝损伤和肝脏内巨噬细胞浸润。
脾脏在肝脏IRI中作为一个促进因素发挥重要作用,因为缺血再灌注期间的脾淤血和实质损伤会促进脾脏白细胞介素-2的分泌以及巨噬细胞向肝脏浸润,进而加重肝损伤。